BioHealth News Archive
935 Prose – The Next Evolution in Innovation.
935 Prose is a 10-story trophy-class, state-of-the-art research/lab building that marries iconic design, and superior lab functionality. It is positioned to recruit and retain…
Read MoreEmmes and MedGenome Launch Genomics Strategic Partnership Focused on Advancing Rare Disease Research
ROCKVILLE, Md., Nov. 15, 2021 /PRNewswire/ -- Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical…
Read MoreTwinLabs in Rockville Fills Up With Four New Tenants – Commercial Observer
The first phase of TwinLabs, a life sciences complex in Rockville, Md., has been fully pre-leased, with four companies taking the entire 25,000 square…
Read MoreMaking The Impossible Possible: A Conversation With Martine Rothblatt
In this riveting What’s Ahead conversation you’ll hear how Martine Rothblatt, creator of SiriusXM, left the communications field entirely to hunt for a cure…
Read MoreBHI EIR Feedback Day November 17th. Register Now!
Are you a biohealth start-up in Maryland, DC or Virginia seeking feedback on your biohealth business idea, pitch deck, or commercialization plan? Schedule your…
Read MoreLife Sciences Business Strategist – Open Position!
/biohealth-news/biohealth-regional-news/13211-life-sciences-business-strategist-open-position
Read MoreMaryland’s Gain Therapeutics, Inc. Announces Breakthrough Pre-Clinical Data of Novel Small Molecules for the Treatment of Parkinson’s Disease and Gaucher Disease
Study results demonstrate first small molecule approach to significantly reduce phosphorylated and aggregated -synuclein and increase GCase protein levels with transport to the lysosomes in…
Read MoreSouth Duvall and Sagamore Ventures to Bring Life Science to City Garage
BALTIMORE, Nov. 10, 2021 /PRNewswire/ -- South Duvall and Sagamore Ventures have announced a partnership to bring more than 100,000 square feet of biotech…
Read MoreREGENXBIO Announces Closing of Eye Care Collaboration Agreement with AbbVie
ROCKVILLE, Md., Nov. 9, 2021 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced the closing of its Collaboration and License Agreement with AbbVie to develop and commercialize…
Read MoreQIAGEN Commits to Reduce Carbon Emissions by Setting Science-Based Target to Reach Net Zero by 2050 | Business Wire
VENLO, Netherlands & HILDEN, Germany--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced its commitment to a science-based target of net-zero carbon…
Read More‘I see amazing momentum.’ Efforts to find HIV cure are speeding up in Maryland | WJLA
The efforts to find a functional cure for HIV are speeding up for one Maryland company after the Data Safety and Monitoring Board found…
Read MoreBioTalk Welcomes Ellington West, CEO & Co-founder of Sonavi Labs
Ellington West, CEO & Co-founder of Sonavi Labs, joins BioTalk to discuss their building the startup, their medical device, and raising funds in the…
Read MoreVirginia Catalyst Awards $1.9 Million in Grants to Support Life Sciences in the Commonwealth | VirginiaBio
The Virginia Catalyst, also known as the Virginia Biosciences Health Research Corporation (VBHRC), announced that it has awarded $1.9 million in grants to three…
Read MoreCIT GAP Funds Invests in Cerillo to Illuminate Scientific Research Possibilities with Innovative Technologies
Richmond, VA, Oct. 13, 2021 (GLOBE NEWSWIRE) — The Center for Innovative Technology (CIT) today announced that CIT GAP Funds, the direct investment program…
Read MoreDeka Biosciences Announces Scientific Advisory Board Members — DEKA BioSciences
Germantown, MD (November 4, 2021) – Deka Biosciences is pleased to announce the appointment of six new members to its Scientific Advisory Board: Aurélien…
Read More